SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Yellow fever outbreak: Sanofi looks to double vaccine production

A recently opened facility will double production of Sanofi Pasteur’s vaccine Stamaril which could alleviate shortages in the wake of recent yellow fever outbreaks in parts of Africa.

Sartorius $90m IntelliCyt acquisition adds cell analysis capabilities

Sartorius has expanded its bio-analytics capabilities through the $90m (€81m) acquisition of IntelliCyt.

Corning adds Biological Industries' xeno-free stem cell medium to portfolio

Corning has struck a deal to commercialise NutriStem hPSC Medium, a xeno-free stem cell culture supplement manufactured by Biological Industries.

Update

Pfizer and GE team on $350m modular biosimilars plant in China

Pfizer has struck a strategic partnership with GE Healthcare to construct and equip a biomanufacturing centre focused on producing biosimilars for China.

Kite opens commercial CAR T-cell plant ahead of anticipated 2017 therapy launch

Kite Pharma has opened a T-cell manufacturing facility in California it says can overcome the logistical problems of autologous therapies and treat up to 5,000 patients per year.

Q&A

Porton replacing older facilities with new biopharma development plant

Porton Biopharma has begun construction on a new bioprocess development and manufacturing facility in the UK equipped with fermentation and down-stream processing suites.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...